US Stock MarketDetailed Quotes

KTRA Kintara Therapeutics

Watchlist
  • 0.1523
  • -0.0033-2.12%
Trading May 10 11:25 ET
5.95MMarket Cap-29P/E (TTM)

Kintara Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
(Q2)Dec 31, 2022
(Q1)Sep 30, 2022
(FY)Jun 30, 2022
(Q4)Jun 30, 2022
(Q3)Mar 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-86.50%658K
-96.95%216K
-86.97%1.54M
-86.97%1.54M
-65.55%3.05M
-65.34%4.87M
-63.36%7.09M
11.80%11.78M
11.80%11.78M
-43.77%8.84M
-Cash and cash equivalents
-86.50%658K
-96.95%216K
-86.97%1.54M
-86.97%1.54M
-65.55%3.05M
-65.34%4.87M
-63.36%7.09M
11.80%11.78M
11.80%11.78M
-43.77%8.84M
Receivables
--414K
----
----
----
----
----
----
----
----
----
-Accounts receivable
--103K
----
----
----
----
----
----
----
----
----
-Taxes receivable
--311K
----
----
----
----
----
----
----
----
----
Prepaid assets
-96.47%114K
--0
--1.08M
--1.08M
--2.15M
--3.23M
----
--0
--0
--0
Other current assets
----
-47.06%567K
-55.35%660K
-55.35%660K
-34.53%821K
15.52%1.08M
39.27%1.07M
95.50%1.48M
95.50%1.48M
245.45%1.25M
Total current assets
-87.08%1.19M
-90.40%783K
-75.34%3.27M
-75.34%3.27M
-40.39%6.02M
-38.81%9.18M
-59.44%8.16M
12.42%13.26M
12.42%13.26M
-39.15%10.09M
Non current assets
Net PPE
-5.41%699K
-7.96%694K
687.78%709K
687.78%709K
589.52%724K
515.83%739K
458.52%754K
-40.00%90K
-40.00%90K
-36.36%105K
Non current prepaid assets
----
----
--0
--0
--0
--0
104.76%4.3M
62.50%2.6M
62.50%2.6M
23.81%2.6M
Total non current assets
-5.41%699K
-86.27%694K
-73.64%709K
-73.64%709K
-73.23%724K
-72.83%739K
126.13%5.05M
53.71%2.69M
53.71%2.69M
19.43%2.71M
Total assets
-80.99%1.89M
-88.82%1.48M
-75.05%3.98M
-75.05%3.98M
-47.34%6.74M
-44.03%9.92M
-40.88%13.21M
17.76%15.95M
17.76%15.95M
-32.12%12.8M
Liabilities
Current liabilities
Payables
-42.27%1.87M
-5.12%3.34M
-22.76%3.08M
-22.76%3.08M
-13.89%2.79M
-5.79%3.24M
17.16%3.52M
43.53%3.99M
43.53%3.99M
59.61%3.24M
-accounts payable
-36.01%1.72M
1.87%3M
-14.84%2.78M
-14.84%2.78M
-6.18%2.61M
-7.05%2.69M
17.25%2.94M
47.32%3.27M
47.32%3.27M
69.12%2.78M
-Due to related parties current
-72.99%148K
-41.01%338K
-58.67%298K
-58.67%298K
-60.70%180K
0.92%548K
16.70%573K
28.52%721K
28.52%721K
18.96%458K
Current liabilities
-42.27%1.87M
-5.12%3.34M
-22.76%3.08M
-22.76%3.08M
-13.89%2.79M
-5.79%3.24M
17.16%3.52M
43.53%3.99M
43.53%3.99M
27.91%3.24M
Non current liabilities
Other non current liabilities
123.75%179K
119.74%167K
1.84%166K
1.84%166K
-4.65%164K
-55.06%80K
-57.54%76K
-10.44%163K
-10.44%163K
-14.85%172K
Total non current liabilities
123.75%179K
119.74%167K
1.84%166K
1.84%166K
-4.65%164K
-55.06%80K
-57.54%76K
-10.44%163K
-10.44%163K
-14.85%172K
Total liabilities
-38.26%2.05M
-2.48%3.5M
-21.79%3.25M
-21.79%3.25M
-13.42%2.95M
-8.21%3.32M
12.96%3.59M
40.21%4.15M
40.21%4.15M
24.75%3.41M
Shareholders'equity
Share capital
-4.79%10.26M
-16.03%10.61M
-15.20%10.65M
-15.20%10.65M
-15.52%10.65M
-16.12%10.78M
-7.93%12.64M
-16.10%12.56M
-16.10%12.56M
-36.21%12.6M
-common stock
400.00%10K
-97.53%2K
100.00%2K
100.00%2K
-95.92%2K
-95.92%2K
68.75%81K
-96.97%1K
-96.97%1K
53.13%49K
-Preferred stock
-4.86%10.25M
-15.50%10.61M
-15.21%10.65M
-15.21%10.65M
-15.21%10.65M
-15.82%10.78M
-8.20%12.55M
-15.92%12.55M
-15.92%12.55M
-36.36%12.55M
Retained earnings
-7.44%-155.54M
-9.34%-154.51M
-11.01%-151.38M
-11.01%-151.38M
-13.09%-148.04M
-15.31%-144.77M
-18.10%-141.32M
-22.59%-136.36M
-22.59%-136.36M
-25.28%-130.91M
Paid-in capital
3.21%145.09M
2.59%141.86M
4.32%141.44M
4.32%141.44M
10.56%141.16M
10.88%140.57M
10.56%138.28M
26.92%135.58M
26.92%135.58M
26.62%127.67M
Gains losses not affecting retained earnings
0.00%21K
0.00%21K
0.00%21K
0.00%21K
0.00%21K
0.00%21K
0.00%21K
0.00%21K
0.00%21K
0.00%21K
Total stockholders'equity
-102.49%-164K
-121.06%-2.03M
-93.80%731K
-93.80%731K
-59.66%3.79M
-53.21%6.6M
-49.81%9.62M
11.47%11.8M
11.47%11.8M
-41.77%9.39M
Total equity
-102.49%-164K
-121.06%-2.03M
-93.80%731K
-93.80%731K
-59.66%3.79M
-53.21%6.6M
-49.81%9.62M
11.47%11.8M
11.47%11.8M
-41.77%9.39M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023(Q3)Mar 31, 2023(Q2)Dec 31, 2022(Q1)Sep 30, 2022(FY)Jun 30, 2022(Q4)Jun 30, 2022(Q3)Mar 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -86.50%658K-96.95%216K-86.97%1.54M-86.97%1.54M-65.55%3.05M-65.34%4.87M-63.36%7.09M11.80%11.78M11.80%11.78M-43.77%8.84M
-Cash and cash equivalents -86.50%658K-96.95%216K-86.97%1.54M-86.97%1.54M-65.55%3.05M-65.34%4.87M-63.36%7.09M11.80%11.78M11.80%11.78M-43.77%8.84M
Receivables --414K------------------------------------
-Accounts receivable --103K------------------------------------
-Taxes receivable --311K------------------------------------
Prepaid assets -96.47%114K--0--1.08M--1.08M--2.15M--3.23M------0--0--0
Other current assets -----47.06%567K-55.35%660K-55.35%660K-34.53%821K15.52%1.08M39.27%1.07M95.50%1.48M95.50%1.48M245.45%1.25M
Total current assets -87.08%1.19M-90.40%783K-75.34%3.27M-75.34%3.27M-40.39%6.02M-38.81%9.18M-59.44%8.16M12.42%13.26M12.42%13.26M-39.15%10.09M
Non current assets
Net PPE -5.41%699K-7.96%694K687.78%709K687.78%709K589.52%724K515.83%739K458.52%754K-40.00%90K-40.00%90K-36.36%105K
Non current prepaid assets ----------0--0--0--0104.76%4.3M62.50%2.6M62.50%2.6M23.81%2.6M
Total non current assets -5.41%699K-86.27%694K-73.64%709K-73.64%709K-73.23%724K-72.83%739K126.13%5.05M53.71%2.69M53.71%2.69M19.43%2.71M
Total assets -80.99%1.89M-88.82%1.48M-75.05%3.98M-75.05%3.98M-47.34%6.74M-44.03%9.92M-40.88%13.21M17.76%15.95M17.76%15.95M-32.12%12.8M
Liabilities
Current liabilities
Payables -42.27%1.87M-5.12%3.34M-22.76%3.08M-22.76%3.08M-13.89%2.79M-5.79%3.24M17.16%3.52M43.53%3.99M43.53%3.99M59.61%3.24M
-accounts payable -36.01%1.72M1.87%3M-14.84%2.78M-14.84%2.78M-6.18%2.61M-7.05%2.69M17.25%2.94M47.32%3.27M47.32%3.27M69.12%2.78M
-Due to related parties current -72.99%148K-41.01%338K-58.67%298K-58.67%298K-60.70%180K0.92%548K16.70%573K28.52%721K28.52%721K18.96%458K
Current liabilities -42.27%1.87M-5.12%3.34M-22.76%3.08M-22.76%3.08M-13.89%2.79M-5.79%3.24M17.16%3.52M43.53%3.99M43.53%3.99M27.91%3.24M
Non current liabilities
Other non current liabilities 123.75%179K119.74%167K1.84%166K1.84%166K-4.65%164K-55.06%80K-57.54%76K-10.44%163K-10.44%163K-14.85%172K
Total non current liabilities 123.75%179K119.74%167K1.84%166K1.84%166K-4.65%164K-55.06%80K-57.54%76K-10.44%163K-10.44%163K-14.85%172K
Total liabilities -38.26%2.05M-2.48%3.5M-21.79%3.25M-21.79%3.25M-13.42%2.95M-8.21%3.32M12.96%3.59M40.21%4.15M40.21%4.15M24.75%3.41M
Shareholders'equity
Share capital -4.79%10.26M-16.03%10.61M-15.20%10.65M-15.20%10.65M-15.52%10.65M-16.12%10.78M-7.93%12.64M-16.10%12.56M-16.10%12.56M-36.21%12.6M
-common stock 400.00%10K-97.53%2K100.00%2K100.00%2K-95.92%2K-95.92%2K68.75%81K-96.97%1K-96.97%1K53.13%49K
-Preferred stock -4.86%10.25M-15.50%10.61M-15.21%10.65M-15.21%10.65M-15.21%10.65M-15.82%10.78M-8.20%12.55M-15.92%12.55M-15.92%12.55M-36.36%12.55M
Retained earnings -7.44%-155.54M-9.34%-154.51M-11.01%-151.38M-11.01%-151.38M-13.09%-148.04M-15.31%-144.77M-18.10%-141.32M-22.59%-136.36M-22.59%-136.36M-25.28%-130.91M
Paid-in capital 3.21%145.09M2.59%141.86M4.32%141.44M4.32%141.44M10.56%141.16M10.88%140.57M10.56%138.28M26.92%135.58M26.92%135.58M26.62%127.67M
Gains losses not affecting retained earnings 0.00%21K0.00%21K0.00%21K0.00%21K0.00%21K0.00%21K0.00%21K0.00%21K0.00%21K0.00%21K
Total stockholders'equity -102.49%-164K-121.06%-2.03M-93.80%731K-93.80%731K-59.66%3.79M-53.21%6.6M-49.81%9.62M11.47%11.8M11.47%11.8M-41.77%9.39M
Total equity -102.49%-164K-121.06%-2.03M-93.80%731K-93.80%731K-59.66%3.79M-53.21%6.6M-49.81%9.62M11.47%11.8M11.47%11.8M-41.77%9.39M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg